178 related articles for article (PubMed ID: 18334510)
1. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
[TBL] [Abstract][Full Text] [Related]
2. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
3. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
[TBL] [Abstract][Full Text] [Related]
4. Trisomy 3 may predict a poor response of gastric MALT lymphoma to Helicobacter pylori eradication therapy.
Taji S; Nomura K; Matsumoto Y; Sakabe H; Yoshida N; Mitsufuji S; Nishida K; Horiike S; Nakamura S; Morita M; Taniwaki M
World J Gastroenterol; 2005 Jan; 11(1):89-93. PubMed ID: 15609403
[TBL] [Abstract][Full Text] [Related]
5. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.
Ye H; Liu H; Attygalle A; Wotherspoon AC; Nicholson AG; Charlotte F; Leblond V; Speight P; Goodlad J; Lavergne-Slove A; Martin-Subero JI; Siebert R; Dogan A; Isaacson PG; Du MQ
Blood; 2003 Aug; 102(3):1012-8. PubMed ID: 12676782
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
[TBL] [Abstract][Full Text] [Related]
7. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.
Raderer M; Streubel B; Wöhrer S; Häfner M; Chott A
Gut; 2006 May; 55(5):616-8. PubMed ID: 16299027
[TBL] [Abstract][Full Text] [Related]
8. Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma.
Kahara T; Iwaki N; Kaya H; Kurokawa T; Yoshida T; Ishikura K; Usuda R
Endocr J; 2011; 58(1):7-12. PubMed ID: 21068513
[TBL] [Abstract][Full Text] [Related]
9. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.
Lévy M; Copie-Bergman C; Molinier-Frenkel V; Riou A; Haioun C; Gaulard P; Delfau-Larue MH; Sobhani I; Leroy K; Delchier JC
Leuk Lymphoma; 2010 Feb; 51(2):284-90. PubMed ID: 20038225
[TBL] [Abstract][Full Text] [Related]
10. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and t(11;18)(q21;q21) translocation in gastric malt lymphoma.
Lima KS; Albuquerque W; Arantes VN; Drummond-Lage AP; Coelho LG
Arq Gastroenterol; 2014; 51(2):84-9. PubMed ID: 25003257
[TBL] [Abstract][Full Text] [Related]
12. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
13. Non-random loss of chromosome 3 during transition of Helicobacter pylori-associated gastric MALT to B-cell MALT lymphoma revealed by fluorescence in situ hybridization.
Banerjee SK; Weston AP; Persons DL; Campbell DR
Cancer Lett; 1997 Dec; 121(1):83-90. PubMed ID: 9459178
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.
Nakamura S; Matsumoto T; Nakamura S; Jo Y; Fujisawa K; Suekane H; Yao T; Tsuneyoshi M; Iida M
J Clin Pathol; 2003 Jan; 56(1):36-42. PubMed ID: 12499431
[TBL] [Abstract][Full Text] [Related]
15. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites.
Streubel B; Simonitsch-Klupp I; Müllauer L; Lamprecht A; Huber D; Siebert R; Stolte M; Trautinger F; Lukas J; Püspök A; Formanek M; Assanasen T; Müller-Hermelink HK; Cerroni L; Raderer M; Chott A
Leukemia; 2004 Oct; 18(10):1722-6. PubMed ID: 15356642
[TBL] [Abstract][Full Text] [Related]
16. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract][Full Text] [Related]
17. MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas.
Streubel B; Seitz G; Stolte M; Birner P; Chott A; Raderer M
Gut; 2006 Nov; 55(11):1581-5. PubMed ID: 16556668
[TBL] [Abstract][Full Text] [Related]
18. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
19. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
20. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
Ohno H; Isoda K
J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
